Skip to main content

2 Result(s)

within Hannah L. Hanania Remove this filter

and

  1. No Access

    Article

    Cutaneous toxicities of mitogen-activated protein kinase inhibitors in children and young adults with neurofibromatosis-1

    Neurofibromatosis type 1 (NF1) is an autosomal dominant disorder which commonly causes neoplasms leading to disfigurement or dysfunction. Mitogen-activated protein kinase inhibitors (MEKi) are generally well-t...

    Brianna C. Peacock, Sanjna Tripathy, Hannah L. Hanania… in Journal of Neuro-Oncology (2024)

  2. No Access

    Article

    Immune checkpoint inhibitor-induced vitiligo in cancer patients: characterization and management

    This study highlights the range of non-melanoma cancers where ICI-induced vitiligo can be present and challenges the exclusivity of this phenomenon to melanoma. We believe our manuscript will encourage awarene...

    Jonathan Lo, Hannah L. Hanania, Monika F. Keiser… in Archives of Dermatological Research (2023)